Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Opexa Therapeutics (OPXA)

0.9699 -0.1001 (-9.3551%)

9/20/2017  3:59pm

Open:

1.1500

Pre. Close:

1.0700

High:

1.1600

Low:

0.9600

Volume:

307,280

Market Cap:

7.43M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.19 - 1.23

1.23 - 1.3

Low:

0.91 - 0.92

0.92 - 0.96

Close:

0.94 - 0.97

0.97 - 1.05

Technical analysis  (as of: 2017-10-20 4:38:50 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 1.35     One year: 1.58

Support:

Support1: 0.88    Support2: 0.71

Resistance:

Resistance1: 1.16    Resistance2: 1.35

Pivot:

0.95

Moving Averages:

MA(5): 1.03     MA(20): 0.93

MA(100): 0.77     MA(250):

MACD:

MACD(12,26): 0.05     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 73.21     %D(3): 79.15

RSI:

RSI(14): 54.42

52-Week:

High: 4.3800  Low: 0.5000  Change(%): -74.3

Average Vol(K):

3-Month: 53641  10-Days 21598

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
OPXA has closed below upper band by 43.9%. Bollinger Bands are 24.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 05 Jul 2017 21:57:33 GMT
Acer Therapeutics Announces Reverse Merger With Houston's Opexa

Thu, 05 Oct 2017 12:22:30 GMT
Acer Therapeutics Appoints Dr. William T. Andrews as Chief Medical Officer

Tue, 19 Sep 2017 21:25:23 GMT
Acer Therapeutics and Opexa Therapeutics Close Merger and Financing

Thu, 12 Oct 2017 12:22:30 GMT
Acer Therapeutics Welcomes Two New Members to its Board of Directors

Mon, 25 Sep 2017 12:22:30 GMT
Acer Therapeutics Reports Positive Results From Pivotal Clinical Trial of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

7.55

% Held by Insiders

% Held by Institutions

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-0.722

EPS Est. Current Year

-0.470

EPS Est. Next Year

-0.220

EPS Est. Next Quarter

-0.120

Forward EPS

Book Value (p.s.)

0.210

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-1.34

P/E Growth Ratio

-0.09

P/BV

4.62

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.